S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

DMN Damon Inc

0.3907

0.0307 (8.53%)

Pre Market

Last Updated: 07:01:26

Delayed by 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Damon (NASDAQ:DMN)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Damon Charts.

Damon (NASDAQ:DMN)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Damon Charts.

Damon Inc News

Damon Provides Operational Business Update and Reports FY25 Q2 Results
Tuesday 18 February 2025 (6 days ago) • PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 14 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 14 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 7 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 6 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Friday 31 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 24 January 2025 (1 month ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Thursday 16 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 10 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 23 December 2024 (2 months ago) • Edgar (US Regulatory)

More Damon Inc News Articles

Accredited Solutions (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Rennova Health (CE)

North Bay Resources (PK)

Kraig Biocraft Laborator... (QB)

Bioelectronics (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions